The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

PURPOSE: The main objective of this study was to investigate the relationship among the clinical characteristics and the frequency of T790M mutation in advanced epidermal growth factor receptor (EGFR)‒mutant lung adenocarcinoma patients with acquired resistance after firstline EGFR‒tyrosine kinase i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yen-Hsiang, Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Chen, Kun-Chieh, Hsu, Chia-Hung, Su, Kang-Yi, Chen, Jeremy J. W., Chen, Huei-Wen, Yu, Sung-Liang, Yang, Tsung-Ying, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192936/
https://www.ncbi.nlm.nih.gov/pubmed/29334606
http://dx.doi.org/10.4143/crt.2017.512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192936/
https://www.ncbi.nlm.nih.gov/pubmed/29334606
http://dx.doi.org/10.4143/crt.2017.512

Ejemplares similares